A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress

Schizophrenia Research

Volumn 65, Issue 1, 2003, Pages 33-38

  Marchbanks, R M ^c   Ryan, Margaret ^a   Day, I N M ^c   Owen, M ^b   McGuffin, P ^b   Whatley, S A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c NONE

Author keywords

Heteroplasmy; mtDNA variant; NADH ubiquinone reductase; Quercetin rutoside; Schizophrenia; Subunit ND4; Superoxide

Indexed keywords

ISOLEUCINE; MITOCHONDRIAL DNA; NEUROLEPTIC AGENT; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RUTOSIDE; THREONINE;

ARTICLE; CADAVER; CONTROLLED STUDY; DNA SEQUENCE; ELECTRON TRANSPORT; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; HETEROPLASMY; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SAMPLING; SCHIZOPHRENIA;

EID: 0242667149     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(03)00011-2     Document Type: Article

References (17)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. 1994;American Psychiatric Association, Washington, DC.
2. Anderson S., Bankier A.T., Barrel B.G., DeBrulin M.H.L., Coulson A.R., Drouin J., Eperon I.C., Nierlich D.P., Roe B.A., Sanger F., Schreier P.H., Smith A.J.H., Staden R., Young I.G. Sequence and organisation of the human mitochondrial genome. Nature. 290:1981;457-465.
3. Burckhardt C., Kelly J.P., Lin Y.H., Filley C.M., Parker W.D. Neuroleptic medications inhibit complex I of the electron transport chain. Ann. Neurol. 33:1993;512-517.
4. Day I.N.M., Humphries S.E. Electrophoresis for genotyping: microtitre array diagonalgel electrophoresis (MADGE) on horizontal polyacrylamide (H-PAGE) gels hydrolink or agarose. Anal. Biochem. 222:1994;389-395.
5. Herrnstadt C., Clevenger W., Ghosh C.C., Anderson C., Eihy E., Miller S., Howell N., Davies R.E. A novel mitochondrial DNA-like sequence in the human nuclear genome. Genomics. 60:1999;67-77.
6. Ikebe S., Tanaka M., Ozawa T. Point mutations of the mitochondrial genome in Parkinson's disease. Mol. Brain Res. 28:1995;281-295.
7. Jacobi F.K., Meyer J., Pusch C.M., Wissinger B. Quantitation of heteroplasmy in mitochondrial DNA mutations by primer extension using Vent-R (exo) DNA polymerase and RFLP analysis. Mutat. Res. 478:2001;141-151.
8. Kogelnik A.M., Lott M.T., Brown M.D., Navathe S.B., Wallace D.C. MITOMAP: a human mitochondrial genome database. Nucleic Acids Res. 24:1996;177-179.
9. Matés J., Perez Gomez C., Nunez de Castro I. Anti-oxidant enzymes and human diseases. Clin. Biochem. 32:1999;595-603.
10. McGuffin P., Farmer A.E., Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness: development and reliability of the opcrit system. Arch. Gen. Psychiat. 48:1994;643-647.
11. Melamed Y., Sirota P., Dicker D.R., Fishman P. Superoxide anion production by neutrophiles derived from peripheral blood of schizophrenic patients. Psychiatry Res. 77:1998;29-34.
12. Mulcrone J., Whatley S.A., Ferrier I.N., Marchbanks R.M. A study of altered gene expression in frontal cortex from schizophrenic patients using differential screening. Schizophr. Res. 14:1995;203-213.
13. Prince J.A., Yassin A.S., Oreland L. Neuroleptic induced mitochondrial enzyme alterations in the rat brain. J. Pharmacol. Exp. Ther. 280:1997;261-267.
14. Tawata M., Ohtaka M., Iwase U., Ikegishi Y., Aida K., Onaya T. New mitochondrial DNA associated with Japanese patients with type 2 diabetes. Diabetes. 47:1998;276-277.
15. Walker J.E., Skehel J.M., Buchanan S.K. Structural analysis of NADH ubiquinone reductase from bovine heart mitochondria. Methods Enzymol. 260:1995;14-34.
16. 5 reductases in brain and lymphocytes from normals and schizophrenic patients. Mol. Psychiatry. 3:1998;227-337.
17. Wing J.K., Cooper J.E., Sartorius N. Measurement and Classification of Psychiatric Illness. 1974;Cambridge Univ. Press, Cambridge.